Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
| gptkbp:ATCCode |
none
|
| gptkbp:CASNumber |
2098603-46-2
|
| gptkbp:developedBy |
gptkb:Dicerna_Pharmaceuticals
|
| gptkbp:drugClass |
gptkb:small_interfering_RNA_(siRNA)
|
| gptkbp:hasMolecularFormula |
C27H32N8O13P2S2
|
| gptkbp:hasUNII |
1Q1K1N2J1F
|
| https://www.w3.org/2000/01/rdf-schema#label |
Nedosiran
|
| gptkbp:indication |
gptkb:primary_hyperoxaluria
|
| gptkbp:mechanismOfAction |
gptkb:RNA_interference
|
| gptkbp:PubChem_CID |
137517073
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:status |
investigational drug
|
| gptkbp:synonym |
gptkb:DCR-PHXC
|
| gptkbp:target |
gptkb:LDHA_gene
|
| gptkbp:bfsParent |
gptkb:Dicerna_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|